Latest Industry Insights
Industry Insight
Flagship Facility Supports Advanced Analytical Science
We spoke to Prof. Oscar Ces, head of the Department of Chemistry at Imperial College London (ICL), to find out about the evolution of ICL’s White City Campus, the Agilent Measurement Suite and what it means for scientists across the board.
Industry Insight
Curing the Image Analysis Headache with Deep Learning
Misha Bashkurov explores how image analysis software with deep learning capabilities can directly address the convoluted and confusing process of traditional image analysis, which often leads to user frustration, bias results, time lost and increased costs.
Industry Insight
Expanding the Short-Read Sequencing Space With Novel RNA-Sequencing Library Preparation Workflows
This article discusses the methodology of using common archived biospecimens for RNA sequencing in oncology applications, such as tumor profiling, introducing challenges and innovative solutions.
Industry Insight
Building the Future of Extracellular Vesicle Isolation
Hans van der Voorn tells us about some of the recent progress in the extracellular vesicle-based diagnostics and therapeutics landscape, particularly the need for industrial-scale EV isolation workflows.
Industry Insight
Expanding the Drug Target Universe: How Next-Generation Proteomics Is Transforming Oncology Research
Cutting-edge mass spectrometry proteomics technologies are accelerating the discovery and validation of novel targets in cancer, opening up new avenues for next-generation cancer therapeutics.
Industry Insight
Next-Generation Proteomics Solutions Set To Accelerate Targeted Therapies
Hear how the capabilities of mass spectrometry (MS)-based proteomics are proving themselves in drug development and discovery and what this means for those working in oncology.
Industry Insight
Failing Faster To Succeed Sooner in Drug Discovery
Revvity announced its newly established Scientific Centre of Excellence in Cambridge, where scientists can outsource their research needs to Revvity experts. Technology Networks visited the site to learn more about how Revvity is supporting its customers in their drug discovery efforts.
Industry Insight
You Have No Moat – The Great AI Democratization Spells New Challenges and Opportunities for SynBio Companies
This article examines the impact of the democratization of computational design and discusses how synthetic biology companies must shift focus if they are to remain competitive.
Industry Insight
Quality Control for RNA Therapeutics: Meeting a Growing Need
New applications for RNA therapeutics are continuously emerging. In this burgeoning space, nucleic acid quantification can help this dynamic therapeutic modality reach its full potential.
Industry Insight
Data-Driven Adaptive Trials: Enhancing Safety, Accelerating Progress and Boosting Economics Through Enhanced Insights
Trial sponsors are faced with vast amounts of diverse data and corresponding endpoints spanning all trial sites linked to their study design. This article explores how interactive response technology can help sponsors overcome these challenges.
Advertisement